111 related articles for article (PubMed ID: 24867136)
1. Risk factors of hyperthyroidism with hepatic function injury: a 4-year retrospective study.
Li C; Tan J; Zhang G; Meng Z; Wang R; Li W; Zheng W
Horm Metab Res; 2015 Mar; 47(3):209-13. PubMed ID: 24867136
[TBL] [Abstract][Full Text] [Related]
2. Analysis of ¹³¹I therapy and correlation factors of Graves' disease patients: a 4-year retrospective study.
Zheng W; Jian T; Guizhi Z; Zhaowei M; Renfei W
Nucl Med Commun; 2012 Jan; 33(1):97-101. PubMed ID: 22008631
[TBL] [Abstract][Full Text] [Related]
3. Hepatic dysfunction related to thyrotropin receptor antibody in patients with Graves' disease.
He K; Hu Y; Xu XH; Mao XM
Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):368-72. PubMed ID: 24941434
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment.
Wang R; Tan J; Zhang G; Zheng W; Li C
Medicine (Baltimore); 2017 Feb; 96(5):e6035. PubMed ID: 28151911
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
7. Establishment of clinical diagnosis model of Graves' disease and Hashimoto's thyroiditis.
Cui Z; Wang Z; Liu X; Cai Y; Xu X; Yang T
J Transl Med; 2019 Jan; 17(1):11. PubMed ID: 30616573
[TBL] [Abstract][Full Text] [Related]
8. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
[TBL] [Abstract][Full Text] [Related]
9. Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy.
Choi YM; Kwak MK; Hong SM; Hong EG
Endocrinol Metab (Seoul); 2019 Sep; 34(3):268-274. PubMed ID: 31565879
[TBL] [Abstract][Full Text] [Related]
10. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
11. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
12. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M
Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
[TBL] [Abstract][Full Text] [Related]
13. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
Hu YM; Liu W; Lu GH
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
[TBL] [Abstract][Full Text] [Related]
14. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].
Zhou J; Du J; Ma B; Liu X; Qiu H; Li J; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):109-13. PubMed ID: 24739642
[TBL] [Abstract][Full Text] [Related]
15. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
Wood LC; Ingbar SH
J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
[TBL] [Abstract][Full Text] [Related]
16. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
17. The effect of radioiodine treatment on the characteristics of TRAb in Graves' disease.
Fang Y; Du WH; Zhang CX; Zhao SX; Song HD; Gao GQ; Dong M
BMC Endocr Disord; 2021 Nov; 21(1):238. PubMed ID: 34847904
[TBL] [Abstract][Full Text] [Related]
18. Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease.
Zhang H; Liang L; Xie Z
Endocr Pract; 2015 Mar; 21(3):258-63. PubMed ID: 25370319
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
20. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]